AnaptysBio Inc.

NASDAQ: ANAB · Real-Time Price · USD
19.53
-0.26 (-1.31%)
At close: Aug 20, 2025, 9:47 AM

AnaptysBio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
22.26M 27.77M 43.11M 30.02M 10.97M 7.18M 9.01M 3.32M 3.46M 1.37M 6.81M 1.29M 1.22M 970K 1.01M 20.89M 30.03M 11.25M
Cost of Revenue
601K n/a n/a 596K 595K 605K 604K 592K 587K 593K 606K 585K 571K 573K 26.78M 22.22M 25.31M 24.18M
Gross Profit
21.66M 27.77M 43.11M 29.42M 10.38M 6.57M 8.4M 2.73M 2.87M 781K 6.2M 708K 645K 397K -25.77M -1.33M 4.71M -12.94M
Operating Income
-26.17M -27.54M -9.67M -22.76M -40.32M -42.2M -42.13M -37.73M -40.14M -44.4M -25.97M -29.63M -27.8M -31.75M -31.16M -6.76M -533K -18.36M
Interest Income
3.65M 4.41M 5.26M 5.32M 4.62M 4.58M 4.88M 4.85M 4.65M 4.49M 3.84M 2.26M 1.11M 342K 68K 64K 104K 195K
Pretax Income
-38.59M -39.28M -21.79M -32.85M -46.65M -43.94M -42.22M -37.31M -39.84M -44.26M -26.39M -33.5M -32.55M -36.26M -32.54M -6.67M -429K -18.16M
Net Income
-38.63M -39.33M -21.78M -32.85M -46.66M -43.94M -42.21M -37.31M -39.84M -48.45M -26.41M -37.37M -37.31M -40.76M -32.54M -6.67M -429K -18.16M
Selling & General & Admin
10.15M 14.13M 10.19M 10.56M 8.85M 11.9M 10.28M 10.17M 10.68M 10.82M 9.41M 8.86M 8.17M 10.2M 5.39M 5.43M 5.25M 5.42M
Research & Development
37.68M 41.18M 42.59M 42.21M 41.84M 36.88M 33.52M 30.88M 32.92M 34.96M 23.37M 22.06M 20.84M 22.52M 26.78M 22.22M 25.31M 24.18M
Other Expenses
n/a n/a n/a n/a n/a -2K 7.34M 1K 3K -4K -4K 4K 6K 6K 1K 33K n/a 3K
Operating Expenses
47.83M 55.31M 52.78M 52.77M 50.7M 48.77M 43.8M 41.05M 43.6M 45.77M 32.78M 30.93M 29.02M 32.72M 32.17M 27.65M 30.56M 29.61M
Interest Expense
19.61M 18.06M 17.4M 15.41M 10.95M 6.32M 4.96M 4.43M 4.36M 4.34M 4.25M 6.13M 5.87M 4.85M 1.45M n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a -441K -442K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
48.43M 55.31M 52.78M 52.77M 51.29M 49.38M 43.8M 41.05M 43.6M 45.77M 32.78M 30.93M 29.02M 32.72M 32.17M 27.65M 30.56M 29.61M
Income Tax Expense
39K 44K -6K n/a 9K n/a 4.87M n/a n/a 4.19M 24K 3.87M 4.75M 4.51M n/a -64K n/a n/a
Shares Outstanding (Basic)
28.81M 30.64M 28.38M 28.89M 27.36M 26.8M 26.59M 26.55M 26.63M 27.95M 28.45M 28.29M 28.2M 27.71M 27.53M 27.44M 27.39M 27.36M
Shares Outstanding (Diluted)
28.81M 30.64M 28.38M 28.89M 27.36M 26.8M 26.59M 26.55M 26.63M 27.95M 28.45M 28.29M 28.2M 27.71M 27.53M 27.44M 27.39M 27.36M
EPS (Basic)
-1.34 -1.28 -0.77 -1.14 -1.71 -1.64 -1.59 -1.41 -1.5 -1.73 -0.93 -1.32 -1.32 -1.47 -1.18 -0.24 -0.02 -0.66
EPS (Diluted)
-1.34 -1.28 -0.77 -1.14 -1.71 -1.64 -1.59 -1.41 -1.5 -1.73 -0.93 -1.32 -1.32 -1.47 -1.18 -0.24 -0.02 -0.66
EBITDA
-18.38M -27.54M -3.79M -16.84M -35.1M -37.01M -36.65M -32.28M -34.9M -39.33M -21.53M -26.78M -26.11M -30.83M -30.99M -6M 356K -18.04M
EBIT
-18.98M -21.22M -4.39M -17.44M -35.7M -37.62M -37.26M -32.88M -35.49M -39.92M -22.14M -27.37M -26.69M -31.4M -30.69M -6.67M -429K -18.16M
Depreciation & Amortization
601K 606K 601K 596K 595K 605K 604K 592K 587K 593K 606K 585K 571K 573K 385K 669K 911K 125K